Depot medroxyprogesterone acetate (DMPA) can prevent pregnancy for up to three months, and is available in a form that can be ...
Self-administered injectable contraceptives, which are progestin-only shots taken at home every three months, have been ...
A new clinical study published in the International Journal of Gynecological Cancer reports encouraging results for women ...
Self-administered injectable contraception has been available in the U.S. for more than two decades, yet a new study found ...
US FDA accepts Camurus’ resubmission of NDA for Oclaiz for treatment of acromegaly: Lund, Sweden Monday, January 12, 2026, 15:00 Hrs [IST] Camurus, an international, science-led ...
“Since most physicians don’t know that this is an option, patients don’t know about it. It’s safe, effective, and puts the ...
New options for testing and treating some of the most common sexually transmitted diseases are becoming available.
ARCALYST- (rilonacept) 2025 net product revenue of $677.5 million (unaudited), representing ~62% year-over-year growth -- ARCALYST 2026 net product revenue expected to be $900 - $920 million -- KPL-38 ...
Wednesday: Mostly cloudy, with a high of 49 and low of 36 degrees.